Entero Healthcare closes trading window from July 1 until Q1FY27 results

0 min read     Updated on 23 Jun 2026, 06:14 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Entero Healthcare Solutions Ltd has closed its trading window for designated persons and their immediate relatives effective July 1, 2026. The window will remain shut until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. The date for the Board Meeting to consider these results will be announced later.

powered bylight_fuzz_icon
43764262

*this image is generated using AI for illustrative purposes only.

Entero Healthcare Solutions Limited has closed its trading window for designated persons and their immediate relatives effective July 1, 2026. This measure is implemented to ensure compliance with the Company's Code of Fair Disclosure of Unpublished Price Sensitive Information. The restriction will remain in place until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026.

The closure follows the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended. The company stated that the specific date for the Board Meeting to consider the unaudited financial results for the quarter will be intimated in due course.

Detail Information
Trading Window Closure Start Date July 01, 2026
Trading Window Reopens 48 hours after Q1FY27 results declaration
Quarter Ended June 30, 2026
Regulation SEBI (Prohibition of Insider Trading) Regulations, 2015

The intimation was addressed to the Head of Listing Compliance Departments at BSE Limited and National Stock Exchange of India Limited. Sanu Kapoor, Vice President- General Counsel, Company Secretary & Compliance Officer, signed the communication on behalf of Entero Healthcare Solutions Limited.

Historical Stock Returns for Entero Healthcare Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+1.47%+6.40%-12.85%+22.61%+3.70%+2.68%

What market expectations are investors setting for Entero Healthcare's Q1 FY27 performance given the early trading window closure?

How might the closure period impact liquidity and trading volumes for Entero Healthcare shares until the results are announced?

Will the upcoming financial results reveal any significant shifts in Entero Healthcare's operational strategy or market position?

Entero Healthcare Solutions
View Company Insights
View All News
like20
dislike

Entero Healthcare Solutions accepts director resignation

1 min read     Updated on 13 Jun 2026, 01:36 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Entero Healthcare Solutions has accepted the resignation of Mr. Kevin Rohitbhai Daftary as a Nominee Director effective June 12, 2026, citing increased professional responsibilities. The company will fill the vacancy upon receiving a fresh nomination from the Prasid Uno Family Trust.

powered bylight_fuzz_icon
42817801

*this image is generated using AI for illustrative purposes only.

Entero Healthcare Solutions has accepted the resignation of Mr. Kevin Rohitbhai Daftary as a Nominee Director on its Board, effective June 12, 2026. The resignation was submitted due to an increase in his professional responsibilities and commitments. Mr. Daftary represented the Prasid Uno Family Trust on the Board. The company confirmed that there are no other material reasons for the resignation beyond those disclosed.

The disclosure was made to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the vacancy caused by the resignation will be filled in due course upon receipt of a fresh nomination from the Prasid Uno Family Trust.

Mr. Kevin Rohitbhai Daftary (DIN: 10637792) served as a Non-Executive Nominee Director. In his resignation letter, he confirmed that the specified reason was the sole material cause for stepping down. He requested the Board to record the resignation and submit the necessary intimations to the Stock Exchanges, the Registrar of Companies (ROC), and the Ministry of Corporate Affairs (MCA).

The following table details the regulatory disclosure regarding the change in directorship:

Sr. No. Particulars Details
1. Reason for change Resignation of Mr. Kevin Rohitbhai Daftary (DIN: 10637792), Nominee Director representing "Prasid Uno Family Trust", due to increase in professional responsibilities and commitments.
2. Date of cessation June 12, 2026
3. Brief Profile Not Applicable
4. Disclosure of relationships

Historical Stock Returns for Entero Healthcare Solutions

1 Day5 Days1 Month6 Months1 Year5 Years
+1.47%+6.40%-12.85%+22.61%+3.70%+2.68%

Who will the Prasid Uno Family Trust nominate to replace Mr. Daftary, and what background will they bring?

How might the timing of the leadership transition impact Entero Healthcare's strategic initiatives in 2026?

Will the new nominee maintain the current level of engagement or shift the Trust's influence on company policy?

Entero Healthcare Solutions
View Company Insights
View All News
like20
dislike

More News on Entero Healthcare Solutions

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:+3.70%